PBSV Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 bal. 2024 @ 20:28):

Stats
Šios dienos apimtis	5 317.00
Vidutinė apimtis	2 653.00
Rinkos kapitalizacija	16.88M
EPS	$0 ( 2024-03-15 )
Kita pelno data	( $0.0300 ) 2024-06-12
Last Dividend	$0.0750 ( 2023-03-28 )
Next Dividend	$0 ( N/A )
P/E	24.50
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-10	Perlysky Dov	Buy	20 000	Stock Option
2024-01-10	Wiesen Irving L	Buy	20 000	Stock Option
2024-01-10	Michel Kirk Wheeler	Buy	20 000	Stock Option
2024-01-10	Spindel Howard	Buy	20 000	Stock Option
2024-01-05	Michel Kirk Wheeler	Buy	20 000	Common Stock

INSIDER POWER
-0.59
Last 100 transactions
Buy: 983 844 \| Sell: 1 082 895

Pharma-Bio Serv, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Pharma-Bio Serv, Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$16.98M
Bruto pelnas:	$5.07M (29.84 %)
EPS:	$0.0570

FY	2023
Pajamos:	$16.98M
Bruto pelnas:	$5.07M (29.84 %)
EPS:	$0.0570

FY	2022
Pajamos:	$19.40M
Bruto pelnas:	$4.88M (25.16 %)
EPS:	$0.0438

FY	2021
Pajamos:	$20.12M
Bruto pelnas:	$5.36M (26.65 %)
EPS:	$-0.0910

Financial Reports:

No articles found.

Pharma-Bio Serv, Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0.0750 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Pharma-Bio Serv, Inc. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.95 - Stable (1.01%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0750	2018-10-12
Last Dividend	$0.0750	2023-03-28
Next Dividend	$0	N/A
Payout Date	2023-04-14
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	$0.450	--
Avg. Dividend % Per Year	0.00%	--
Score	2.94	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.95
Div. Directional Score	7.93	--

Next Divdend (Est)
(2024-10-14)

$0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

2.94

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for PNK

Symbol	Title	Last dividend	Frequency	Yearly Dividend
ENBP	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
CMTV	Ex Dividend Knight	2023-10-12	Quarterly	0.00%
TNCAF	Ex Dividend Junior	2023-08-30	Quarterly	0.00%
RSKIA	Ex Dividend Knight	2023-09-28	Annually	0.00%
NUVR	Ex Dividend Junior	2023-06-02	Quarterly	0.00%
FMFG	Ex Dividend Knight	2023-06-01	Semi-Annually	0.00%
CZFS	Ex Dividend Knight	2023-09-14	Quarterly	0.00%
WCRS	Ex Dividend Junior	2023-08-21	Quarterly	0.00%
BEBE	Ex Dividend Junior	2023-09-18	Quarterly	0.00%
SFDL	Ex Dividend Knight	2023-08-30	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0405	1.500	9.19	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0319	1.200	8.94	10.00	[0 - 0.3]
returnOnEquityTTM	0.0395	1.500	-0.673	-1.009	[0.1 - 1]
payoutRatioTTM	2.81	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	5.10	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.97	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.744	1.500	1.425	2.14	[0.2 - 2]
debtRatioTTM	0.0161	-1.500	9.73	-10.00	[0 - 0.6]
interestCoverageTTM	1.422	1.000	-0.585	-0.585	[3 - 30]
operatingCashFlowPerShareTTM	0.0758	2.00	9.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0758	2.00	9.96	10.00	[0 - 20]
debtEquityRatioTTM	0.0219	-1.500	9.91	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.289	1.000	8.52	8.52	[0.2 - 0.8]
operatingProfitMarginTTM	0.0232	1.000	-1.536	-1.536	[0.1 - 0.6]
cashFlowToDebtRatioTTM	5.62	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.786	0.800	8.09	6.47	[0.5 - 2]
Total Score				10.90

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	27.53	1.000	7.32	0	[1 - 100]
returnOnEquityTTM	0.0395	2.50	-0.432	-1.009	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0758	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	10.20	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0758	2.00	9.97	10.00	[0 - 30]
payoutRatioTTM	2.81	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-0.137	1.500	-4.24	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.115	1.000	9.62	0	[0.1 - 0.5]
Total Score				4.95

Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.